Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 USD | +1.19% | -0.29% | +0.15% |
Mar. 13 | Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating | MT |
Mar. 12 | ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.15% | 181M | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |
- Stock
- Equities
- Stock ClearPoint Neuro, Inc. - Nasdaq
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro Appoints Mazin Sabra Chief Operating Officer